The global alpha emitters market is undergoing rapid changes due to revolutionary advances in oncology treatment, nuclear medicine, and radiotherapy therapies. The industry valuation is expected to reach USD 4.5 billion by 2025 and exceed USD 40.1 billion by 2035, driven by a CAGR of 22.9% from 2025 to 2035. Alpha emitters are used for cancer therapy. Highly ionizing alpha particles...